SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Kramm CM)
 

Search: WFRF:(Kramm CM) > Drug sensitivity pr...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003593naa a2200793 4500
001oai:prod.swepub.kib.ki.se:151504311
003SwePub
008240701s2022 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1515043112 URI
024a https://doi.org/10.1038/s41698-022-00335-y2 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Peterziel, H4 aut
2451 0a Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
264 c 2022-12-27
264 1b Springer Science and Business Media LLC,c 2022
520 a The international precision oncology program INFORM enrolls relapsed/refractory pediatric cancer patients for comprehensive molecular analysis. We report a two-year pilot study implementing ex vivo drug sensitivity profiling (DSP) using a library of 75–78 clinically relevant drugs. We included 132 viable tumor samples from 35 pediatric oncology centers in seven countries. DSP was conducted on multicellular fresh tumor tissue spheroid cultures in 384-well plates with an overall mean processing time of three weeks. In 89 cases (67%), sufficient viable tissue was received; 69 (78%) passed internal quality controls. The DSP results matched the identified molecular targets, including BRAF, ALK, MET, and TP53 status. Drug vulnerabilities were identified in 80% of cases lacking actionable (very) high-evidence molecular events, adding value to the molecular data. Striking parallels between clinical courses and the DSP results were observed in selected patients. Overall, DSP in clinical real-time is feasible in international multicenter precision oncology programs.
700a Jamaladdin, N4 aut
700a ElHarouni, D4 aut
700a Gerloff, XF4 aut
700a Herter, S4 aut
700a Fiesel, P4 aut
700a Berker, Y4 aut
700a Blattner-Johnson, M4 aut
700a Schramm, K4 aut
700a Jones, BC4 aut
700a Reuss, D4 aut
700a Turunen, L4 aut
700a Friedenauer, A4 aut
700a Holland-Letz, T4 aut
700a Sill, M4 aut
700a Weiser, L4 aut
700a Previti, C4 aut
700a Balasubramanian, G4 aut
700a Gerber, NU4 aut
700a Gojo, J4 aut
700a Hutter, C4 aut
700a Ora, I4 aut
700a Lohi, O4 aut
700a Kattamis, A4 aut
700a de Wilde, B4 aut
700a Westermann, F4 aut
700a Tippelt, S4 aut
700a Graf, N4 aut
700a Nathrath, M4 aut
700a Sparber-Sauer, M4 aut
700a Sehested, A4 aut
700a Kramm, CM4 aut
700a Dirksen, U4 aut
700a Kallioniemi, Ou Karolinska Institutet4 aut
700a Pfister, SM4 aut
700a van Tilburg, CM4 aut
700a Jones, DTW4 aut
700a Saarela, J4 aut
700a Pietiaeinen, V4 aut
700a Jaeger, N4 aut
700a Schlesner, M4 aut
700a Kopp-Schneider, A4 aut
700a Oppermann, S4 aut
700a Milde, T4 aut
700a Witt, O4 aut
700a Oehme, I4 aut
710a Karolinska Institutet4 org
773t NPJ precision oncologyd : Springer Science and Business Media LLCg 6:1, s. 94-q 6:1<94-x 2397-768X
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:151504311
8564 8u https://doi.org/10.1038/s41698-022-00335-y

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view